| Risperidone | Paroxetine | Statistics |
---|---|---|---|
N | 33 | 23 | Â |
Gender |  |  | χ2 = 0.74; n.s. |
   Males (%) | 8 (24) | 8 (35) |  |
   Females (%) | 25 (76) | 15 (65) |  |
Diagnosis |  |  | χ2 = 0.74; n.s. |
   Panic Disorder (%) | 24 (73) | 19 (83) |  |
   MDD (%) | 9 (27) | 4 (17) |  |
Age: mean (± SD)1 | 38.82 (9.74) | 42.57 (14.34) | t = 1.16; n.s. |
Terminated (%)2 | 13 (39)4 | 14 (61)4 | χ2 = 2.50; n.s. |
   LTF/Non-compliance (%) | 9 (69)5 | 5 (36)5 | χ2 = 0.873; n.s. |
   Adverse Effects (%) | 2 (15)5 | 1 (11)5 |  |
   Lack of Response (%) | 2 (15)5 | 1 (11)5 |  |